MARRAS, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 5.542
EU - Europa 2.655
AS - Asia 1.936
SA - Sud America 272
Continente sconosciuto - Info sul continente non disponibili 85
AF - Africa 49
OC - Oceania 9
Totale 10.548
Nazione #
US - Stati Uniti d'America 5.439
IT - Italia 1.317
SG - Singapore 697
CN - Cina 460
UA - Ucraina 356
VN - Vietnam 249
HK - Hong Kong 237
BR - Brasile 230
SE - Svezia 182
TR - Turchia 169
GB - Regno Unito 135
DE - Germania 131
FI - Finlandia 127
IE - Irlanda 110
FR - Francia 104
RU - Federazione Russa 68
CA - Canada 49
IN - India 36
MX - Messico 33
NL - Olanda 26
BD - Bangladesh 25
ZA - Sudafrica 21
NG - Nigeria 15
JP - Giappone 14
CZ - Repubblica Ceca 13
PL - Polonia 12
AR - Argentina 11
BE - Belgio 11
LU - Lussemburgo 11
ID - Indonesia 9
ES - Italia 8
LT - Lituania 8
CL - Cile 7
IQ - Iraq 7
AT - Austria 6
EC - Ecuador 6
NZ - Nuova Zelanda 6
VE - Venezuela 6
CR - Costa Rica 5
EU - Europa 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CH - Svizzera 4
CO - Colombia 4
IL - Israele 4
MD - Moldavia 4
MY - Malesia 4
PE - Perù 4
SA - Arabia Saudita 4
AU - Australia 3
HN - Honduras 3
KE - Kenya 3
MA - Marocco 3
PT - Portogallo 3
UZ - Uzbekistan 3
AL - Albania 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
HU - Ungheria 2
JM - Giamaica 2
KR - Corea 2
NI - Nicaragua 2
NP - Nepal 2
PH - Filippine 2
PK - Pakistan 2
PR - Porto Rico 2
RS - Serbia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MK - Macedonia 1
OM - Oman 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 10.469
Città #
Milan 824
Fairfield 452
San Jose 438
Singapore 420
Dallas 384
Ashburn 382
Woodbridge 356
Chandler 326
Jacksonville 274
Houston 243
Hong Kong 233
Ann Arbor 200
Seattle 194
Wilmington 176
Council Bluffs 155
Cambridge 148
Beijing 143
Chicago 127
Dublin 110
Princeton 108
Dearborn 100
Nyköping 95
The Dalles 88
Izmir 87
Boardman 86
Los Angeles 82
Rome 71
Dong Ket 67
Lauterbourg 67
New York 60
Como 59
Santa Clara 55
Ho Chi Minh City 52
London 37
San Mateo 37
Hanoi 36
Munich 36
San Diego 33
Helsinki 31
Ogden 25
Orem 24
Mexico City 23
São Paulo 23
Redmond 20
Salt Lake City 18
Buffalo 17
Chennai 16
Verona 16
Abuja 15
Denver 15
Varese 15
Atlanta 14
Elk Grove Village 14
Shanghai 14
Tokyo 14
Phoenix 13
Guangzhou 12
Manchester 12
Poplar 12
Rozzano 12
Brooklyn 11
Brussels 11
Montreal 11
Brno 10
Hefei 10
Stockholm 10
Turku 10
Amsterdam 9
Ottawa 9
Paris 9
Rio de Janeiro 9
San Francisco 9
Shenzhen 9
Warsaw 9
Boston 8
Grahamstown 8
Kunming 8
Washington 8
Gavirate 7
Johannesburg 7
Tianjin 7
Toronto 7
Belo Horizonte 6
Bologna 6
Las Vegas 6
Miami 6
Mumbai 6
Nanjing 6
San Genesio Ed Uniti 6
Ankara 5
Auburn Hills 5
Basingstoke 5
Detroit 5
Frankfurt am Main 5
Tampa 5
Turin 5
Berlin 4
Changsha 4
Dhaka 4
Dulles 4
Totale 7.505
Nome #
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid. 266
Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up 238
Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination. 233
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex 227
Discrepancies between in silico and in vitro data in the functional analysis of a breast cancer-associated polymorphism in the XRCC6/Ku70 gene. 226
EGFR-Targeted Photodynamic Treatment of Triple Negative Breast Cancer Cell Lines Using Porphyrin–Peptide Conjugates: Synthesis and Mechanistic Insight 225
Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients 225
Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg). 220
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 212
Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction. 211
Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity. 210
Chronic bacterial prostatitis: enterococcal disease? 208
Activity of Serenoa repens, lycopene and selenium on prostatic disease: evidences and hypotheses. 205
A severely symptomatic case of anaerobic chronic bacterial prostatitis successfully resolved with moxifloxacin therapy. 202
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes 199
New BODIPYs for photodynamic therapy (PDT): Synthesis and activity on human cancer cell lines 199
Semen analysis in chronic bacterial prostatitis: diagnostic and therapeutic implications. 197
Antimicrobial therapy for chronic bacterial prostatitis. 197
Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations. 197
Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis 192
Synthesis and photodynamic activity of novel non-symmetrical diaryl porphyrins against cancer cell lines. 189
Emerging second-line therapies for advanced, androgen deprivation-refractory prostate cancer in the post-docetaxel setting 186
Prevention and modulation of aminoglycoside ototoxicity (Review) 183
Resistance of human leukemic cell lines to 1-beta-D-arabinofuranosylcytosine: characterization of an experimental model 171
Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: A biopsy study in chronic prostatitis patients 167
Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome 163
Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection. 161
Anti-cancer potential of edible/medicinal mushrooms in breast cancer 159
X-ray crystal structures, density functional theory and docking on deacetylase enzyme for antiproliferative activity of hispolon derivatives on HCT116 colon cancer 159
The radiosensitizing effect of Ku70/80 knockdown in MCF10A cells irradiated with X-rays and p(66)+Be(40) neutrons. 157
Mild and Effective Polymerization of Dopamine on Keratin Films for Innovative Photoactivable and Biocompatible Coated Materials 149
Influence of infection on the distribution patterns of NIH-Chronic Prostatitis Symptom Index scores in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). 146
Lentivirus-mediated RNA interference of Ku70 to enhance radiosensitivity of human mammary epithelial cells. 145
Targeting mitochondrial ROS production to reverse the Epithelial-Mesenchymal Transition in breast cancer cells 142
Chronic prostatitis and erectile dysfunction: results from a cross-sectional study. 140
Inflammation, Prostatitis, Proliferative Inflammatory Atrophy: "fertile ground" for prostate cancer development? 138
Luteolin impairs hypoxia adaptation and progression in human breast and colon cancer cells. 132
Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(IV) complexes to obtain antiproliferative agents against human glioblastoma cells 128
Combination pharmacological therapy lowers serum prostate-specific antigen in patients with chronic prostatitis: Implications for prostate cancer screening. 127
Tumor suppressor activity of the delta isoform of protein kinase C. 125
Free and poly-methyl-methacrylate-bounded BODIPYs: photodynamic and antimigratory effects in 2D and 3D cancer models 125
Photodynamic effects of positive-charged diaryl porphyrins on multicellular tumor spheroids 123
Lentivirus-mediated RNA interference of Ku70 to enhance radiosensitivity of human mammary epithelial cells: Implications for breast cancer onset. 122
Involvement of inflammation and Proliferative Inflammatory Atrophy in prostate cancer development. 120
Arene-Ruthenium(II) curcuminoid complexes as photosensitizer agents for antineoplastic and antimicrobial photodynamic therapy: in vitro and in vivo insights 115
Phototoxicity of two positive-charged diaryl porphyrins in multicellular tumor spheroids 112
p53 is a key effector of tumor suppressor PKCdelta in human colon cancer cells. 109
Novel non-symmetrical diaryl porphyrins inhibil cellular proliferation and migration of human cancer cell lines 108
HIF-1 alpha knockdown by RNA interference potentiates the cytotoxic effect of doxorubicin in human colon carcinoma cells. 107
Molecular and genetic characterization of the T309C missense transduction in BRCA1 codon 64 (C64R). 106
Gli inibitori dell'angiogenesi: un nuovo approccio alla terapia dei tumori? 106
Sexual dysfunction: a critical component of the new UPOINT Chronic Prostatitis/Chronic Pelvic Pain Syndrome phenotyping system. 106
Materials.it 2016 106
Overcoming position effects: a comparative analysis of lentiviral vectors carrying multiple genes. 105
Could the Length of the Alkyl Chain Affect the Photodynamic Activity of 5,10,15,20-Tetrakis(1-alkylpyridinium-4-yl)porphyrins? 102
Evaluation of Nanoparticles Covalently Bound with BODIPY for Their Photodynamic Therapy Applicability 101
Photodynamic activity of novel diaryl porphyrins against cancer cell lines 99
Anticancer Effect of Nature-Inspired Indolizine-Based Pentathiepines in 2D and 3D Cellular Model 96
Novel non-symmetrical diaryl porphyrins inhibit cellular proliferation and migration of human cancer cell lines. 96
The radiosensitizing effect of Ku70-80 knockdown by RNA interference in the MCF10A breast epithelial cell line irradiated with low-LET X-rays and high-LET radiotherapy neutrons. 92
Terapia genica: una sfida per la medicina del nuovo millennio. 91
Ruthenium(II)-arene curcuminoid complexes as photosensitizer agents for antineoplastic and antimicrobial photodynamic therapy: in vitro and in vivo insights. 89
The Pharmacogenetics of Aminoglycoside-induced Ototoxicity. 85
BODIPYs-carrier Poly-Methyl-Methacrylate Nanoparticles for Photodynamic Therapy 84
Free and poly-methyl-methacrylate-bounded BODIPYs for photodynamic therapy 83
Mechanisms of the Antineoplastic Effects of New Fluoroquinolones in 2D and 3D Human Breast and Bladder Cancer Cell Lines 83
Free and poly-methyl methacrylate-bounded BODIPYs for photodynamic therapy 76
Green Tea Components: In Vitro and In Vivo Evidence for Their Anticancer Potential in Colon Cancer 73
Synthesis and biological evaluation of porphyrin-peptide conjugates targeting triple-negative breast cancer cells 67
Polydopamine-Coated Liposomes for Methylene Blue Delivery in Anticancer Photodynamic Therapy: Effects in 2D and 3D Cellular Models 64
null 60
Synthesis and evaluation of the biological activity of porphyrin-peptide conjugates with specific targeting against Triple Negative Breast Cancer (TNBC) 54
Platinum(IV) combo prodrugs containing cyclohexane-1R,2Rdiamine, valproic acid, and perillic acid as a multiaction chemotherapeutic platform for colon cancer 48
Synthesis, X-ray diffraction and anti-proliferative biological activity of hispolon derivatives and their (η6-p-cymene)(Hispolonato)Ruthenium[II] chloride complexes 39
Impact of vitamin D plasma levels on in vitro natural killer cell cytotoxicity against non-small cell lung carcinoma in the presence of nivolumab 21
Silybum marianum-Derived Compounds in Prostate Cancer: Mechanisms of Action and Translational Potential 10
Novel BODIPY-loaded liposomes enhance cellular uptake and PDT efficacy in 2D and 3D models 9
Totale 10.548
Categoria #
all - tutte 42.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.813


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022427 0 0 41 62 14 17 25 35 23 78 53 79
2022/2023792 84 69 76 88 52 170 5 96 83 19 36 14
2023/20241.358 215 223 212 232 268 48 22 29 40 19 9 41
2024/20251.227 24 16 215 33 47 61 47 61 101 128 154 340
2025/20263.136 236 197 343 427 321 186 556 182 286 192 136 74
2026/2027356 86 155 115 0 0 0 0 0 0 0 0 0
Totale 10.548